None Portrait The Chair
- Hansard -

I remind Members gently that questions have to be within the scope of the Bill and that this session has to be completed by 12.30 pm. I call Gordon Marsden to open the questions.

Gordon Marsden Portrait Mr Gordon Marsden (Blackpool South) (Lab)
- Hansard - -

Q 119 Thank you, Mr Hanson, and our thanks to our witnesses this morning for appearing. I will kick off the session with a general question put within a timeframe, if I can put it that way. It was clear on Second Reading that there were a number of concerns—I put it no stronger—about the variable geometry of the new structures. The submissions we have had from the various research councils and the Royal Society underline that fact. Since then, we have had some of those issues about the variable geometry between the UK and its constituent parts emphasised and underlined by the implications of Brexit. Do the members of the panel still hold strongly to the reservations that were submitted to us? How do they think the situation post-23 June has altered the position?

Professor Philip Nelson: I am happy to answer first. The result of the referendum has given still more impetus to the need for reform in research and innovation. One of the key features of the review that Sir Paul Nurse undertook was to ensure a stronger voice for science and innovation in the UK and I think that to backtrack on that at this stage would be entirely wrong. I think we need absolutely to ensure we have a strong voice through the Brexit negotiations.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q Without wanting to do too much cross-examination, can I take you up on that point? We were not suggesting backtracking on it. What we were saying—you will know this well, Professor Nelson, because you will have seen the correspondence about this and the House of Lords’ report—was that there are strong concerns about the structures here. I am asking you to say not just, “We need to get on with it more because of Brexit,” but particularly how the variable geometry has affected some of the concerns that you have received.

Professor Philip Nelson: If I understood you correctly, by variable geometry you mean the fact that we are having nine councils under one single body.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Not simply that. That is an issue, but there are also the continued concerns about what the split is going to be for funding between the UK and the England aspects of that, and the issues about the independence of Innovate UK and so on. No disrespect, but those are not things that can be blandly dealt with by just saying. “We ought to get on with it.”

Professor Philip Nelson: I completely agree with that. I want to emphasise the fact that we have spent a lot of time engaging with Government on these issues and have been deeply involved in constructing the so-called variable geometry and made our views very clear on this. We have been very clear about the principles that we feel we need to subscribe to to ensure that we do retain the strength of UK research and innovation. Those include things such as dual support, the Haldane principle and the disciplinary identities being very clear in the existing research councils. I think we have made all those points very clearly throughout this process.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q Have you got any results?

Professor Philip Nelson: I think we have. I think the policy intent as stated in the White Paper is very clear and I can find several references to exactly the sort of points that we have been making through the process, so I do not feel too uncomfortable about that at all at this stage.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q Perhaps I could ask Professor Leyser and Dr McKernan to give their views.

Professor Ottoline Leyser: I should say that our understanding at the Royal Society is that the clear intention of the Bill is to implement the recommendations of the Nurse review and those recommendations have been broadly welcomed by the community for a variety of reasons. In terms of variable geometry, on the one hand, people have expressed concerns about, for example, ensuring a robust implementation of the Haldane principle so that money winds up in particular pots of money that are under the power of the individual research councils to spend; but at the same time, there is wide recognition that the ability of those research councils to collaborate at present and to consider the research base across the piece is currently compromised by the way in which the divisions between the research councils are so hard. Therefore, the variable geometry is to be welcomed, as long as it does not simultaneously destroy the strength of our research base that has grown up through the Haldane principle and the power of individual research councils to allocate money independently.

From our point of view, the key question is the extent to which that opportunity for flexibility while maintaining our strong research base is enshrined in the Bill. We do not have huge concerns about that. There are particular phrases that we have submitted in our concerns that touch on those questions, but overall we think that the direction of travel is absolutely right.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q The devil is in the detail, is it not? A question that has been raised by a number of people is about the new powers that are given to the office for students, particularly in terms of research councils. I am sure that colleagues will want to probe that point. Are you are worried about those things—that the connection between the research councils and the OFS in the Bill is not yet strongly established and that, in extremis, that could result in situations where the research councils have powers taken out of their hands?

Professor Ottoline Leyser: The relationship between UK Research and Innovation and the OFS needs strengthening. The specific recommendations about the obligations of those organisations to interact, as we have laid out in our written response, need to be strengthened and embedded across the system because there are a number of issues where a lack of co-ordination between those bodies could cause major problems—for example, in maintaining the health of disciplines, in postgraduate research training, and in shared facilities and the efficiency of spend across Government. We understand why there has been this division and clearly there are some advantages to be had from that, but as usual, if you are making a change you need to ensure that you do not then have unintended consequences on the parts left behind.

Dr Ruth McKernan: From the perspective of Innovate UK and small and medium-sized enterprises, SMEs get 30% of the Horizon 2020 funding. It is very important for them. Last year, it was as much money as they got from Innovate UK. With the formation of UKRI, the opportunity to do the research that businesses need to be competitive is a big opportunity and it is a win for us. With Brexit, the opportunity to help companies scale and become really competitive is even more important than it was before. Post-Brexit, UKRI is more important.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q You have expressed in previous correspondence not just to me, but to other people, a concern—if I can put it that way—that the buccaneering spirit of Innovation UK does not get entangled in this new relationship. Do you feel you have the guarantees you need about that in the Bill at the moment?

Dr Ruth McKernan: There are some really great things about the Bill and it was nice to hear John Kingman say that he would encourage Innovate UK to go further and faster. There are some really good parts such as not changing the name or the purpose.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q What about the not-so-good parts?

Dr Ruth McKernan: I am getting to that. Another good part is maintaining the business focus. There are three areas in particular on which we need to be absolutely sure that the intent and what was in the White Paper is still there in the Bill. The first of those is the business experience of the board and the Innovate UK champion, which is very clear in the White Paper. As I understand it, that is possible and enabled through the Bill, but I think that the balance of business and research experience is very broad and could be tightened up a bit.

The second area is the financial tools. We are keen to be able to use things such as seed loans and equity, and other councils within UKRI have dipped a toe into that. Seed funding through Rainbow has been done through the Biotechnology and Biological Sciences Research Council and the Science and Technology Facilities Council, and the Medical Research Council has done a very forward-thinking thing by creating MRC Technology, which looks at royalty streams from work it has done.

We need to be absolutely clear, in how the Bill is finalised, that we ensure we have as much flexibility as the research councils have had and some of our enterprise partners have. We work very closely with Scottish Enterprise, which uses more financial tools than we currently have, and Enterprise Northern Ireland. We want to move at speed and to empower companies to grow in scale and be really competitive, but we must ensure we have the flexibility to do that and not slow down our clock speed. I think there is a bit of work to do looking at that in more detail.

The third point is about institutes and research. The Bill gives us the great opportunity to look across the whole spectrum, from very basic research institutes to catapults. They go from future-thinking research to business-focused, short-term delivery. At the moment, as I understand it, if Innovate UK wanted to create an institute and employ researchers to do the work that businesses need, we absolutely could. I am not sure, within the letter of the Bill, that we are still going to be able to do that. I think that probably needs to be looked at. These are all conversations that we are already having with the people who are putting the proper wording on the Bill, so it will not be a surprise that those are some of our concerns. They are the main three.

Matt Warman Portrait Matt Warman (Boston and Skegness) (Con)
- Hansard - - - Excerpts

Q The Science and Technology Committee has heard from all three of your organisations about the UKRI future. I think the consensus was that UKRI allows the research councils to be more than the sum of their parts. Can you talk a little about how we ensure that is actually the case, rather than just hoping it happens?

Professor Philip Nelson: That is the critical question. The objective is absolutely to make us more than the sum of our parts. I think it will take, in practical terms, a lot of good will and hard work on the part of the new executive chairs of the new research councils, when they come into being.

I think the principles are clear, and I believe they are accepted by the Government, that we still need those seven discipline-facing identities and that those disciplines have clearly delegated budgets, with authority over them. That is one of the core principles that we have expounded. Set against that, we absolutely need to enable the councils to work together better and incentivise that working through some means. Those details have to be thought about more and worked out, but I certainly detect a will on the part of the councils to do better collectively. We have had a programme across RCUK for about a year now which is aimed at achieving precisely that. I think that the move to a single accounting officer will probably enable that to happen more easily, so I do not have too many concerns about it happening. It should be set up to enable that.

I think we absolutely need to retain the good things that the councils already do. Paul Nurse acknowledged that we are highly effective organisations, and the key trick is to make sure we retain that while enabling better collaboration. I am confident that that can be done.

--- Later in debate ---
Mark Pawsey Portrait Mark Pawsey (Rugby) (Con)
- Hansard - - - Excerpts

Q I have a question—mainly, I think, for Dr McKernan, but I am interested in other views. The UK has traditionally had a reputation for cutting-edge research, brilliant innovation and coming up with ideas, with the commercial exploitation taking place in other countries. Does the Bill mean that the UK manufacturing sector is more likely to benefit from the research that takes place here?

Dr Ruth McKernan: I do not think the Bill specifically addresses that, but indirectly I think there is a benefit from having business close to research such that the benefits of research and innovation could be more easily adopted in business and provide a competitive edge.

Some 50% of productivity growth comes from innovation, so to the extent that we can help businesses grow more quickly because we can help them innovate, they have a chance to be more globally competitive, although many other factors in terms of access to capital and the competitive environment come into that. The Bill can only ever relate to a small component of your question.

Professor Philip Nelson: An awful lot of our work is focused on doing exactly what you are asking and I think that we will continue to do that. I think, frankly, this country has got an awful lot better at converting its scientific output into application in the last 20 years, and I would hope we will continue on that upward path.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q My question is principally for you, Professor Nelson, but perhaps Professor Leyser will want to comment on the thrust of it.

You spent your academic life in acoustics, engineering and technology, but of course your position as chair of the board means that you have to recognise the needs and aspirations of non-science areas, and particularly the humanities and social sciences. Does it worry you that in the whole thrust of the Bill, and certainly the thrust of the White Paper, there seems to be little to say about the role of the social sciences and arts? Does it worry you that the Academy of Social Sciences is concerned that the Bill gives the power to do away with research councils by statutory instrument, which is often a rubber stamp? Are you concerned about that, and, if you are, what representations have you made to the Government?

Professor Philip Nelson: We are concerned about that. In fact, we absolutely hold dear the continued existence of those seven disciplinary councils. We have made it very clear to the Government that we felt that what we had was an effective base from which to work and that we did not want to abandon that in any regard. Personally, I have a huge sense of support for social sciences, arts and humanities. Those councils are extremely well read—sorry, well led.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

And well read.

Professor Philip Nelson: Yes—Freudian slip. I would be very concerned about any sense that they were to be abolished. I would have deep concerns about that. In terms of exactly what the Bill says, that is one of the details on which we will be working with BEIS to ensure that we have the right sort of protections. I do not think that any Minister would undertake such an action lightly. I imagine they would want to consult widely before changing any sense of direction.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q You would like to think so, but we have to legislate for a generation, and not for the best Ministers but for the worst. Do you think something should be made more explicit in the Bill?

Professor Philip Nelson: I think there is scope for doing that. Again, it is down to the detail. For the research councils, it is a very important principle.

Professor Ottoline Leyser: We would agree that there should be an obligation to consult before any drastic reorganisation of research councils—that is in our paper. In principle, UKRI has the opportunity to allow the social sciences, arts and humanities to be better included and considered across the research base.

There is a tendency to say, “And arts and humanities”, rather than it being brought across, but the interdisciplinary working will integrate those disciplines much more strongly and allow the obvious benefits, in terms of policy developments in the social sciences, design and manufacturing. For those kinds of issues where that expertise is clearly crucial, it should be strengthened by bringing everybody together in a single body.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q All I can say is that as a medievalist, a historian and politician, I am grateful on all three counts.

Professor Ottoline Leyser: I am the daughter of two medieval historians, so I am very familiar with the medieval history argument.

None Portrait The Chair
- Hansard -

Are there any further questions to the panel? No. I thank the panel for their contributions and stand them down. If the next panel is available, we can commence the session two minutes or so early.

Examination of Witnesses

Douglas Blackstock and Sorana Vieru gave evidence.

--- Later in debate ---
Matt Warman Portrait Matt Warman
- Hansard - - - Excerpts

Q I think this question is mainly for Mr Blackstock. The Bill moves towards a risk-based approach to regulation. Could you just talk us through your views on the advantages of that?

Douglas Blackstock: The advantage of a risk-based approach for an organisation such as us and the office for students is that you can direct resources where they are most needed. You can pay attention in a system like that, which is proportionate, to the track record and the ongoing performance of particular institutions. An example that I have used in many speeches over the past year is: why would we visit the University of Oxford as often as we would visit the college above the kebab shop on Oxford Street? They have different track records. It allows you to move to a system described in the White Paper, the Bill and the recent quality reforms—what I would call intelligent monitoring—which is where you actually look at the performance of institutions and then have an intervention that is proportionate to the risk that exists in that institution. That is the right way to go. It is what has happened in Australia, and the United States is probably a year or so behind where we are.

Sorana Vieru: With a move to a more risk-based approach, we really need to ensure that we capture the student voice throughout. With the current system, students really welcome the review opportunity to get changes and to get those from the students as well. A move that goes to student outcomes and annual reports is important to get a robust way of capturing student feedback and ensuring that it is acted on.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q I have a couple of questions for Douglas Blackstock, if I may.

None Portrait The Chair
- Hansard -

Just one question.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Okay. On the issue of alternative providers, the QAA’s most recent survey shows that shortcomings were uncovered in a third. Are the proposals for registering alternative providers adequate? That is obviously a point that Sorana might want to comment on. The other point is about the process on the creation of the OFS. The complicated architecture between QAA, HEFCE and all the rest of it will take up to two or three years. Are either of you alarmed that that will create problems for the UK brand abroad?

Douglas Blackstock: Starting with the current arrangements, I think that they have been proved. We have made significant steps through the introduction, in our activities, of financial sustainability checks, and HEFCE has been doing that as well. The creation of the register will strengthen it too. It is a sign of the system’s success that the providers that are doing well have come out well. We have now had the first alternative providers that have commended judgments and are doing well, but where there have been shortcomings, they have been exposed in public reporting.

In the five years we have come through since we took on the review of alternative providers, the market has reduced in terms of the number of providers, but the stronger ones have survived and are doing better in reviews. We recently published an analysis of our reviews of alternative providers, and those that have a partnership with a university do well. They come out well, because they have a mature relationship.

Sorana Vieru: I am alarmed by the fact that these are risky reforms that are being pursued at risky times, and I cannot see where student representation sits. With the split of knowledge exchange—with it coming out of HEFCE and going into UKRI—do postgraduate research students fall through the cracks? I would like to see more clarity about where those functions are. We are creating an office for students without having student representation designated on the board or the quality assessment committee, or any statutory duty placed on that office to work with and consult students to represent their interests.

Jo Churchill Portrait Jo Churchill
- Hansard - - - Excerpts

Q Mr Blackstock, you have said that you welcome the single register, financial stability and so on, but you are the quality body for higher education, so do you believe that the necessary quality safeguards are in place to do that intelligent monitoring that you spoke about and to ensure that there is quality for all students of any age at any institution?

Douglas Blackstock: We are in the process of reform anyway, and there has been a detailed consultation and a move towards this risk-based system, which involves an annual provider review. There is much more regular checking up on how institutions are performing, and then a series of triggers to investigate where there are problems. That is all strong and good, and I welcome it. My one residual concern was put rather nicely to me recently by a vice-chancellor of a prestigious university: “If we never look at the best, how will we know what good looks like?” That is my one concern—that we need to work with the system on an enhancement approach that would help improve quality, perhaps learning the lessons from the quality enhancement framework that we operate in partnership with others in Scotland.

--- Later in debate ---
None Portrait The Chair
- Hansard -

Thank you, Minister. We have an opportunity now for questions. We have very limited time— 11 minutes—and I already have six Members who wish to speak.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Q I do not think anyone round this table would disagree with any of the aspirations, Jo, but the devil is in the detail. You have referred already to the length of time that it has taken to get this Bill—since Mr Hanson came into Parliament. We need to put something forward that will last for 20 or 25 years. We need 21st-century structures, not 20th-century structures, for 21st-century solutions. We will be pressing you on some of those issues, particularly about part-time and mature students in future.

I do want to press you specifically on this. You talked about the research landscape. You have come forward with this very complicated structure for the future. Are you actually engaging with what parliamentarians have said? There was a major 12-page letter sent to you by the Chairman of the House of Lords Committee at the end of June, which essentially duffed you up—not you personally but the Department—

Gordon Marsden Portrait Mr Marsden
- Hansard - -

Well, you wouldn’t. You’re the Whip [Laughter.]

None Portrait The Chair
- Hansard -

Order. Can I remind colleagues that we have 10 minutes and we have to have succinct questions? Otherwise we will run out of time and people will be frustrated. There are lots of opportunities to question the Minister.

Gordon Marsden Portrait Mr Marsden
- Hansard - -

I will be very specific. What have you done to respond to the widespread criticisms of the way in which you have put the future of the research councils together, set out in the letter that Lord Selborne sent you on 30 June?

Joseph Johnson: Thanks, Gordon. I do not think your comments reflect the evidence that you have been hearing this morning and Tuesday from witnesses such as Professor Sir Leszek Borysiewicz and others. They saw huge merits in the creation of UKRI and were unanimous in agreeing that we should incorporate Innovate UK within that body.

Of course, we received Lord Selborne’s letter and I gave a very comprehensive reply to it, which has been published and is in the public domain. We strongly believe that there are huge benefits to the business community from having a better understanding of what is going on in the research base and the opportunities that are coming out of it. We think there are huge advantages to the research base of being more aware of the needs of business. There is a big synergy there to be exploited.

Amanda Milling Portrait Amanda Milling
- Hansard - - - Excerpts

Q Good afternoon, Minister. On Tuesday, Professor Gaskell said that Universities UK had advocated a well-regulated register of higher education providers. Do you feel that the Bill will enable that?

Joseph Johnson: Yes—one of the centrepieces of the Bill is the creation of the register. For the first time we are going to have a unified list of institutions that are recognised, that meet a defined quality standard and that are able to assure students that the institution that they are going to has been through a quality threshold. This is a really important unifying mechanism that creates coherence in what is currently a very fragmented regulatory architecture, where HEFCE regulates a number of publicly funded institutions, BIS directly regulates alternative providers and there is a third huge universe of providers who are outside of both regimes altogether.

For the first time we will have a register, which Mary Curnock Cook, the chief executive of UCAS, said on Tuesday would be of huge benefit to people applying to university and wanting to have some kind of assurance that the institution they were thinking of going to had been through some basic sanitary and hygiene checks.